Parallel Advisors, LLC Bio Techne Corp Transaction History

Parallel Advisors, LLC

  • $4.87 Billion
  • Q2 2025

A detailed history of Parallel Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,503 shares of TECH stock, worth $79,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,503
Previous 2,097 28.33%
Holding current value
$79,403
Previous $122,000 36.89%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025
SELL
$46.66 - $58.38 $27,716 - $34,677
-594 Reduced 28.33%
1,503 $77,000
Q1 2025

Apr 07, 2025
SELL
$58.47 - $78.75 $38,999 - $52,526
-667 Reduced 24.13%
2,097 $122,000
Q4 2024

Feb 10, 2025
BUY
$66.37 - $78.17 $28,870 - $34,003
435 Added 18.68%
2,764 $199,000
Q3 2024

Nov 13, 2024
SELL
$70.96 - $82.35 $23,345 - $27,093
-329 Reduced 12.38%
2,329 $186,000
Q2 2024

Aug 08, 2024
BUY
$62.12 - $84.15 $2,857 - $3,870
46 Added 1.76%
2,658 $190,000
Q1 2024

May 06, 2024
BUY
$65.98 - $77.09 $30,680 - $35,846
465 Added 21.66%
2,612 $183,000
Q4 2023

Feb 09, 2024
BUY
$52.83 - $78.22 $16,060 - $23,778
304 Added 16.49%
2,147 $165,000
Q3 2023

May 20, 2024
SELL
$67.52 - $89.42 $18,365 - $24,322
-272 Reduced 12.86%
1,843 $125,000
Q3 2023

Nov 13, 2023
SELL
$67.52 - $89.42 $18,365 - $24,322
-272 Reduced 12.86%
1,843 $125,000
Q2 2023

May 20, 2024
BUY
$73.76 - $85.98 $17,481 - $20,377
237 Added 12.62%
2,115 $172,000
Q2 2023

Aug 04, 2023
BUY
$73.76 - $85.98 $17,481 - $20,377
237 Added 12.62%
2,115 $172,000
Q1 2023

May 20, 2024
SELL
$71.62 - $86.62 $52,569 - $63,579
-734 Reduced 28.1%
1,878 $139,000
Q1 2023

Apr 25, 2023
SELL
$71.62 - $86.62 $62,166 - $75,186
-868 Reduced 31.61%
1,878 $139,000
Q4 2022

Feb 03, 2023
BUY
$80.67 - $352.29 $168,761 - $736,990
2,092 Added 319.88%
2,746 $227,000
Q3 2022

Nov 10, 2022
SELL
$282.54 - $391.85 $6,498 - $9,012
-23 Reduced 3.4%
654 $186,000
Q2 2022

Aug 01, 2022
SELL
$322.67 - $449.65 $34,525 - $48,112
-107 Reduced 13.65%
677 $235,000
Q1 2022

Apr 28, 2022
SELL
$353.85 - $487.79 $9,907 - $13,658
-28 Reduced 3.45%
784 $347,000
Q4 2021

Jan 20, 2022
BUY
$456.15 - $525.06 $50,176 - $57,756
110 Added 15.67%
812 $420,000
Q3 2021

Nov 02, 2021
BUY
$444.87 - $538.88 $40,483 - $49,038
91 Added 14.89%
702 $340,000
Q2 2021

Aug 06, 2021
BUY
$387.35 - $450.26 $16,656 - $19,361
43 Added 7.57%
611 $275,000
Q1 2021

Apr 23, 2021
BUY
$314.62 - $411.0 $18,247 - $23,838
58 Added 11.37%
568 $217,000
Q4 2020

Feb 02, 2021
BUY
$246.9 - $321.87 $20,245 - $26,393
82 Added 19.16%
510 $162,000
Q3 2020

Oct 27, 2020
BUY
$232.22 - $282.96 $9,985 - $12,167
43 Added 11.17%
428 $106,000
Q2 2020

Jul 16, 2020
BUY
$185.43 - $279.56 $20,026 - $30,192
108 Added 38.99%
385 $101,000
Q1 2020

Apr 27, 2020
BUY
$161.17 - $221.51 $4,673 - $6,423
29 Added 11.69%
277 $52,000
Q4 2019

Jan 30, 2020
BUY
$189.68 - $222.09 $25,606 - $29,982
135 Added 119.47%
248 $54,000
Q3 2019

Nov 01, 2019
SELL
$183.56 - $216.72 $2,019 - $2,383
-11 Reduced 8.87%
113 $22,000
Q4 2018

Feb 05, 2019
SELL
$132.75 - $203.8 $4,380 - $6,725
-33 Reduced 21.02%
124 $17,000
Q3 2018

Nov 01, 2018
SELL
$147.44 - $204.11 $3,391 - $4,694
-23 Reduced 12.78%
157 $32,000
Q2 2018

Jul 30, 2018
BUY
$144.9 - $165.58 $2,608 - $2,980
18 Added 11.11%
180 $26,000
Q3 2017

Nov 15, 2017
BUY
$113.59 - $123.78 $18,401 - $20,052
162 New
162 $20,000
Q3 2017

Nov 14, 2017
SELL
$113.59 - $123.78 $9,314 - $10,149
-82 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
82
82 $10,000

Others Institutions Holding TECH

# of Institutions
608
Shares Held
159M
Call Options Held
109K
Put Options Held
26K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.07B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email